PURE Bioscience, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2011 | -198.5% | -198.5% | -162.2% |
| FY2012 | -1,086.8% | -1,086.8% | -199.4% |
| FY2013 | 774.1% | -2,905.7% | -372.0% |
| FY2014 | -65,000.0% | -65,000.0% | -594.4% |
| FY2015 | -320.1% | -320.1% | -233.9% |
| FY2016 | -286.1% | -286.1% | -190.0% |
| FY2017 | -485.5% | -485.5% | -163.6% |
| FY2018 | -581.0% | -581.0% | -289.0% |
| FY2019 | -550.8% | -550.8% | -339.2% |
| FY2020 | 0.1% | 0.1% | 0.1% |
| FY2021 | -69.6% | -69.6% | -53.9% |
| FY2022 | -89.3% | -89.3% | -77.9% |
| FY2023 | -1,456.3% | -1,456.3% | -217.0% |
| FY2024 | 117.0% | 117.0% | -409.5% |
| FY2025 | 46.9% | 46.9% | -226.7% |
| FY2026 | 38.8% | -1,223.2% | -208.1% |